share_log

Cantor Fitzgerald Maintains Overweight on AvePoint, Raises Price Target to $10

Cantor Fitzgerald Maintains Overweight on AvePoint, Raises Price Target to $10

坎托·菲茨杰拉德维持对AvePoint的增持,将目标股价提高至10美元
Benzinga ·  2023/08/10 11:33

Cantor Fitzgerald analyst Brett Knoblauch maintains AvePoint (NASDAQ:AVPT) with a Overweight and raises the price target from $8 to $10.

坎托·菲茨杰拉德分析师布雷特·诺布劳赫维持AvePoint(纳斯达克股票代码:AVPT)的增持,并将目标股价从8美元上调至10美元。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发